Results 91 to 98 of about 463 (98)

Recent progress in alkynylation with hypervalent iodine reagents.

Chem Commun (Camb), 2023
Le Du E, Waser J.
europepmc   +1 more source

SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme. [PDF]

ACS Med Chem Lett
Blankenship LR, Yang KS, Vulupala VR, Alugubelli YR, Khatua K, Coleman D, Ma XR, Sankaran B, Cho CD, Ma Y, Neuman BW, Xu S, Liu WR.   +12 more
europepmc   +1 more source

Chemical probes for enzyme imaging: challenges in design, synthesis and biomedical applications. [PDF]

Chem Sci
Nguyen J, Zabijak M, Poręba M.
europepmc   +1 more source

Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases. [PDF]

Sci Rep, 2018
Pant A, Kumar R, Wani NA, Verma S, Sharma R, Pande V, Saxena AK, Dixit R, Rai R, Pandey KC.   +9 more
europepmc   +1 more source

Guanidines Conjugated with Cell-Penetrating Peptides: A New Approach for the Development of Antileishmanial Molecules. [PDF]

Molecules
de Souza JVM, Costa NCS, Brasil MCOA, Dos Anjos LR, de Menezes RPB, Zampieri EH, de Lima JS, Velasquez AMA, Scotti L, Scotti MT, Graminha MAS, Gonzalez ERP, Cilli EM.   +12 more
europepmc   +1 more source

Peptide Dimerization as a Strategy for the Development of Antileishmanial Compounds. [PDF]

Molecules
Coelho NCS, Portuondo DLF, Lima J, Velásquez AMA, Valente V, Carlos IZ, Cilli EM, Graminha MAS.   +7 more
europepmc   +1 more source

Human β-Defensin 3 Inhibition of P. gingivalis LPS-Induced IL-1β Production by BV-2 Microglia through Suppression of Cathepsins B and L. [PDF]

Cells
Inoue E, Minatozaki S, Shimizu S, Miyamoto S, Jo M, Ni J, Tozaki-Saitoh H, Oda K, Nonaka S, Nakanishi H.   +9 more
europepmc   +1 more source

Unnatural Amino Acids: Strategies, Designs, and Applications in Medicinal Chemistry and Drug Discovery. [PDF]

J Med Chem
Sharma KK, Sharma K, Rao K, Sharma A, Rathod GK, Aaghaz S, Sehra N, Parmar R, VanVeller B, Jain R.   +9 more
europepmc   +1 more source